Overview

Intrathecal Nalbuphine Versus Midazolam in Cesarean Section

Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Adequate pain management is important to facilitate the functional recovery and enable the patients for rapid rehabilitation of normal activity . Various adjuvants were being used with intrathecal bupivacain to prolong & improve postoperative pain relief in patients undergoing cesarean section . The aim of this study was to compare intrathecal nalbuphine versus intrathecal midazolam in patient undergoing cesarean section. The investigators primary aims were to compare the characteristics of sensory and motor block, the effective analgesic time, and analgesic requirement. Secondary aims were to compare the side effects, sedation score and apgare score.
Phase:
Phase 1
Details
Lead Sponsor:
Zagazig University
Treatments:
Bupivacaine
Midazolam
Nalbuphine